New Technologies
John Babitt EY.jpg
New TechnologiesWill 2022 Be Medtech's Biggest Year for M&A?Will 2022 Be Medtech's Biggest Year for M&A?
Will 2022 be the year of medtech M&A. EY’s John Babitt joins us to talk about acquisition trends and deal-making activity in the latest episode of Let’s Talk Medtech.
Sign up for the QMED & MD+DI Daily newsletter.